title: Rhodotorula mucilaginosa skin infection in a patient treated with sorafenib.
authors.affiliation: Plastic and Reconstructive Surgery Unit, Campus Bio-Medico University, Rome, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Coppola
authors.forename: S
authors.initials: S
authors.lastname: Zanframundo
authors.forename: M Verona
authors.initials: MV
authors.lastname: Rinati
authors.forename: M
authors.initials: M
authors.lastname: Carbotti
authors.forename: A
authors.initials: A
authors.lastname: Graziano
authors.forename: G
authors.initials: G
authors.lastname: Galati
authors.forename: L
authors.initials: L
authors.lastname: De Florio
authors.forename: V
authors.initials: V
authors.lastname: Panasiti
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003881:Dermatomycoses / Q000139:chemically induced* / Q000382:microbiology; D006801:Humans; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D009536:Niacinamide / Q000009:adverse effects / Q000031:analogs & derivatives*; D009894:Opportunistic Infections / Q000139:chemically induced* / Q000382:microbiology; D010671:Phenylurea Compounds / Q000009:adverse effects*; D012248:Rhodotorula; D000077157:Sorafenib
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D009536:Niacinamide; D000077157:Sorafenib